Becton Dickinson cuts annual profit forecast to reflect sale of biosciences and diagnostics unit

Core Viewpoint - Medical device maker Becton Dickinson has revised its profit forecast for fiscal year 2026, reflecting the impact of the separation and sale of its biosciences and diagnostics unit [1] Group 1 - The company has adjusted its outlook to account for the recent strategic changes involving its biosciences and diagnostics unit [1]